JANUVIA
Film-coated tablet, 100mg
RxActive license
Active substance (INN)
sitagliptin
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength100mg
PackagingUkupno 28 film tableta u blisteru (2x14) u kartonskoj kutiji
ManufacturerMerck Sharp & Dohme B.V., Netherlands
Therapeutic groupAlimentary tract and metabolism (A10BH01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateApril 18, 2024
Analogs in Montenegro
18Other medicines with the same active substance
ALTUXERINRx
Film-coated tablet, 100mgDAGRADUORx
Film-coated tablet, 100mg/10mgDOLISTARx
Film-coated tablet, 50mgDOLISTARx
Film-coated tablet, 100mgDOLISTARx
Film-coated tablet, 25mgDOLISTA DUORx
Film-coated tablet, 850mg + 50mgDOLISTA DUORx
Film-coated tablet, 1000mg + 50mgEPROCLIVRx
Film-coated tablet, 1000mg + 50mgEPROCLIVRx
Film-coated tablet, 1000mg + 50mgJanumetRx
Film-coated tablet, 850mg + 50mgJanumetRx
Film-coated tablet, 1000mg + 50mgMAYMETSIRx
Film-coated tablet, 850mg + 50mgMAYMETSIRx
Film-coated tablet, 850mg + 50mgMAYMETSIRx
Film-coated tablet, 1000mg + 50mgMAYMETSIRx
Film-coated tablet, 1000mg + 50mgMAYSIGLURx
Film-coated tablet, 100mgMAYSIGLURx
Film-coated tablet, 50mgSITAGLIPTIN/METFORMINKLORID TEVARx
Film-coated tablet, 50mg + 1000mgSource: CInMED register